Dr. Picken received her MD and PhD degrees from the Medical University of Gdansk, Poland. She completed her residency training in anatomic and clinical pathology at New York University Medical Center, New York, followed by a fellowship in Immunopathology at the same institution. Presently, Dr. Picken is a Professor of Pathology and Internal Medicine, and Director of the Transplant Pathology, Immunofluorescence and Electron Microscopy Laboratories at Loyola University Medical Center. Dr. Picken is the past-President of the Renal Pathology Society. Dr. Picken holds full medical licensure in Illinois and New York State (inactive). She is certified by the American Board of Pathology in anatomic and clinical pathology and immunopathology. Dr. Picken’s clinical responsibilities include general surgical pathology, with special interest in medical kidney diseases and urologic pathology, amyloid and related disorders, transplant pathology, cardiac pathology, electron microscopy and immunofluorescence. Dr. Picken is particularly interested in the application of molecular techniques and technology to the practice of anatomic pathology.

Editor-In-Chief Professor Loyola University Medical Center USA

Dr. Picken’s research interests have focused on various aspects of protein folding disorders, particularly amyloid and related disorders. Dr. Picken also has a long publication record in experimental pathology using animal models of disease. She is involved in a long-term collaborative study on the pathology of hypertensive injury in a rat remnant kidney model and genetic susceptibility to hypertensive injury. To date, she has published >100 scientific articles in peer-reviewed journals and several book chapters, including a chapter on “Renal Diseases associated with plasma cell dyscrasias, amyloidoses, Waldenstrom macroglobulinemia, and cryoglobulinemic nephropathies” in Heptinstall’s Pathology of the Kidney. Dr Picken is also the editor of the upcoming book entitled “Amyloidosis and related disorders: a primer for pathologists

Daniel Mais received his Doctor of Medicine at Baylor College of Medicine later, worked as a pathologist for US Army Medical Corps, Pathology Group of Louisiana, Michigan Multispecialty Physicians, Baptist Health System. He is currently serving as a director of surgical pathology in University of Texas Health Science Center San Antonio, USA.

University of Texas Health Science Center San Antonio, USA

Dr. Singh has two major interests. The first is her focus on laboratory test stewardship, and on the mechanisms used to optimize the type and frequency of physician test orders to achieve better clinical outcomes and reduce waste. Her second interest is clinical informatics and the use of machine learning to determine key drivers in healthcare. Dr. Singh leads TRUU-Lab a national initiative to give rational and easily understood names to lab tests. She is board-certified in Clinical Pathology, and in Clinical Informatics.

Clinical Pathology & Immunology

Clinical Pathology & Immunology

More than 18 years experience in community and academic hospitals and health care systems including over ten years as director of hematology laboratories for the second largest healthcare system in Southeast Wisconsin, and medical director and hematopathologist with one of the largest cancer focused reference laboratory in the country. More than six years in hospital functions as member of credentialing committee, internal medicine committee, and electronic medical records implementation committee. Graduated from an MBA program in Healthcare Management at Loyola University Chicago. Currently medical director at NeoGenomics Laboratory an oncology-focused reference laboratory.

VA Central California Health Care System, CA, USA

Licensed histologist focused on providing skills and knowledge . Proficient in all area of histology. I am currently working with NIH-National Cancer Institute (NCI-Match Clinical Trial Laboratory). I am also interested in academic work as well, and perhaps advising continuing education on cancer related diseases.

Histology Laboratory at MD Anderson Cancer Center, USA

Professor UT Southwestern Medical Center USA

Breast Cancer Cancer Therapeutics Hepatocellular Carcinoma Tumor Suppressors

Dr. Anil Parwani is a Professor of Pathology at The Ohio State University. He serves as the Vice Chair and Director of Anatomical Pathology. Dr. Parwani is also the Director of Pathology Informatics and Director of the Digital Pathology Shared Resource at The James Cancer Hospital. His research is focused on diagnostic and prognostic markers in bladder and prostate cancer, and molecular classification of renal cell carcinoma. Dr. Parwani has expertise in the area of surgical pathology, viral immunology and pathology informatics including designing quality assurance tools, bio banking informatics, clinical and research data integration, applications of whole slide imaging, digital imaging, telepathology, image analysis and lab automation. Dr. Parwani has authored over 300 peer-reviewed articles in major scientific journals and several books and book chapters. Dr. Parwani is the Editor-in-chief of Diagnostic Pathology and one of the Editors of the Journal of Pathology Informatics.

Anatomic and Clinical Pathology

Chris is a professor and department head in the Department of Pathology and Laboratory Medicine and medical director of Alberta Public Laboratories, South Sector (formerly Calgary Laboratory Services). He holds cross-appointments in the departments of Family Medicine and Community Health Sciences and is a member of the O’Brien Institute for Public Health and Arnie Charbonneau Cancer Institute.

Clinical Research and Pathology

Dr. Quiñones-Mateu’s successful career encompasses over 20 years of productive research in HIV/AIDS in three different countries. He holds a bachelor’s degree in Biology from the Universidad Central de Venezuela and completed his Ph.D. in Molecular Biology at the Centro de Biologia Molecular “Severo Ochoa”, Universidad Autonoma de Madrid, Spain. He continued his training as a Postdoctoral Fellow in the Department of Medicine at Case Western Reserve University (CWRU), prior to becoming Assistant Professor in the Department of Virology, The Cleveland Clinic. Recently, and following a five-year hiatus in the corporate world (Diagnostic Hybrids, A Quidel Company), Dr. Quinones-Mateu returned to the academia as Assistant Professor of Pathology at CWRU and Scientific Director of the University Hospital Translational Laboratory (www.uhtl.org).

Assistant Professor Case Western Reserve University USA

Despite the success of current antiretroviral therapy, it is difficult to durably control HIV replication in part because of the extraordinary capacity of the virus to develop resistance to antiretroviral drugs. This extreme genetic variability is one of the main obstacles for HIV disease prevention, treatment and overall control of the HIV epidemic. Our research focuses on understanding the mechanisms and clinical consequences of drug resistant viruses, including transmission and pathogenicity studies using, among other systems, state-of-the-art next generation sequencing technology.

Wenxin Zheng, M.D., tenured Professor of Pathology and Obstetrics & Gynecology, American board certified pathologist, director of the Gynecologic Pathology and Molecular Pathology program at the University of Arizona, graduated from Fudan University and trained at Columbia University, Cornell University, and Brown University Medical Centers in anatomic pathology and gynecologic pathology, Selected by US News and World Report in 2012 as one of the top American pathologists (http://health.usnews.com/top-doctors), Dr. Zheng is an internationally well recognized gynecologic pathologist with outstanding expertise in every aspect of gynecologic pathology. His original research contributions include type II endometrial precancers and its carcinogenesis, tubal origin of low-grade ovarian serous cancer, hormonal etiology of ovarian epithelial cancers, and the cell origin of ovarian endometriosis. Dr. Zheng has been created a novel approach called “One-Stop Cervical Care” to make a definitive diagnose and treat cervical precancers in less than 2 hours.

Director of Molecular Pathology Professor University of Arizona USA

Pathology, Obstetrics and Gynecology and Molecular Pathology

Dr Monalisa Sur did her anatomical pathology training in University of Witwatersrand, Johanesburg, South Africa and Hammersmith, London. She obtained her fellowship, F.C.Path (S.A.) Anatomical Pathology, College of Medicine of South Africa. On completion of her training, she was awarded the James Gear Prize for the most outstanding resident produced by the South African Institute of Medical Research and Education (SAIMR) and the College of Medicine, Coulter gold medal for most outstanding performance as a candidate in the fellowship exams of the College of Medicine of South Africa in laboratory medicine. She also holds a Masters in Medicine (MMED) with Cum Laude from University of Witwatersrand, Johanesburg, SA. She has subsequently acquired qualifications from U.K (F.R.C.Path (Anatomical Pathology), Fellow of the Royal College of Pathologists, United Kingdom) and Canada (FRCP,C) She currently is a Professor, Department of Pathology and Molecular Medicine, Division of Anatomical Pathology, McMaster University, Hamilton, and Program Director, Anatomical Pathology Residency Training Program, & Staff Pathologist, (HRLMP)Department of Anatomical Pathology, Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada. Within the division of Anatomical pathology, her primary area of interest in service, education and research is Hematopathology. She has over 50 publications including book chapters, journal articles and abstract publications. She has given numerous presentations and conducted workshops at local, national and international pathology meetings.Under her supervision, residents have won awards at the local Annual Resident Research day for Pathology and Molecular Medicine, Canadian Association of Pathologists conference and United States and Canadian Academy of Pathology conference.

Professor MCMaster University Canada

Her research interests are in hematopathology and gynaecologic-oncologic pathology. Her interests in research in these areas range from clinical pathologic correlations and their impact on patient management to identifying prognostic markers in various tumours through ancillary tests such as immunohistochemistry and molecular techniques.

Dr. Sara Copeland Shalin has completed Ph.D at Baylor College of Medicine. Cureently she is working as an assistant professor at University of Arkansas for Medical Sciences, U.S.A

Assistant Professor Departments of Pathology and Dermatology University of Arkansas for Medical Sciences U.S.A

Dr. Sara Copeland Shalin research interest focus on proteomic analysis of melanoma as well as several projects investigating other skin cancers and inflammatory skin conditions.

Assistant Professor Loyola University Medical Center USA

Natural history of melanocytic tumor regression and its implications for treatment of malignant melanoma.

Director of Dermatopathology University of Arizona USA

Dr. Lian’s research interests focus on Dermato-oncology, including but not limited to Melanoma, Basal Cell Carcinoma, Squamous Cell carcinoma, Merkel cell Carcinoma and Pre-Malignant pathological Processes in skin. She is collaborating with Dr. Zhang and very interested in understanding the role of Nrf2 in skin cancer. She is also the expert frequently consulted for other cancer processes such as Lymphoma and metastatic malignancy of skin.

Dr. Mojdeh Naghashpour joined NeoGenomics in 2018 as a Hematopathologist. Throughout her medical career, Dr. Naghashpour has served in both academic and clinical centers throughout Florida, including Moffitt Cancer Center and University of South Florida in Tampa, FL. Dr. Naghashpour received her medical degree from the University of Miami Miller School of Medicine. Her post-graduate education includes a PhD in Physics, a PhD in Physiology and Molecular Biology, and post-doctoral research at the University of Miami, FL. She received her residency training in anatomic andclinical pathology at the University of Pennsylvania, followed by fellowship training in Hematopathology at Moffitt Cancer Center in Tampa, FL, where she served as a Hematopathologist and Assistant Professor at the University of South Florida. She iscertified by the American Board of Pathology in Anatomic and Clinical Pathology and Hematopathology. As a life-long scientist, Dr. Naghashpour has authored a multitude of peer-reviewed articles, book chapters and scientific abstracts.

Visiting Fellow Department Of Hematopathology University Of Texas MD Anderson Cancer Center USA

Olga K. Weinberg, MD; Director of Hematopathology and Flow Cytometry, Department of Pathology, Harvard Medical School, MA, USA

Director of Hematopathology and Flow Cytometry, Department of Pathology, Harvard Medical School, MA, USA

Dr. Lan Peng received her medical degree from Hunan Medical University in China before she moved to the U.S. She worked as a researcher at various institutions including the Harvard Medical School and Thomas Jefferson University before resuming her medical training, which include her residency in pathology at New York University during 2003-2007, a surgical pathology fellowship at MD Anderson Cancer Center in Houston in 2007-2008, and a Liver and GI pathology fellowship at Mount Sinai Medical Center in New York in 2008-2009, where she has received specialty training for liver pathology with Drs. Swan Thung and Isabel Fiel, and GI pathology with Dr. Noam Harpaz. Before joining the University of Texas Southwestern Medical Center in 2011, Dr. Peng spent two years as an Assistant Professor with the University of Massachusetts Medical School. Her primary clinical focus is transplant liver and gastrointestinal pathology.

Director UT Southwestern Medical Center USA

Medical Liver Disease Pancreatic Neoplasm Transplant Liver Pathology

Associate Professor McMaster University Canada

Forensic Pathology

Assistant Professor Emory University Hospitals USA

Head and neck pathology, gynecologic pathology, cytopathology, and frozen sections particularly interested on salivary gland neoplasms, thyroid neoplasms, and ovarian neuroendocrine tumors.

Assistant Professor Department of Pathology University of Illinois USA

Uveal melanoma -extracellular matrix interactions. Development of three dimensional tumor cell culture models for improved oncolytic virotherapy.

Elizabeth M. Kurian, M.D., received her medical degree from the University of Texas Medical School at Houston, followed by a combined anatomic and clinical pathology residency at the University of Texas Health Science Center at San Antonio. Dr. Kurian gained expertise in cytopathology through the fellowship program at MD Anderson Cancer Center. Before coming to UT Southwestern Medical Center, Dr. Kurian spent three years as an Assistant Professor at the University of Massachusetts Medical School. While there, she completed the institution’s first Junior Faculty Development Program and served as an Associate Course Director for Cancer Concepts, an introductory first-year medical school course. Her translational research interests include using automation for cytologic evaluation, and applications of immunohistochemistry or molecular testing using cytology or small biopsies for diagnosis or prognostic utility. She is an editorial member of the American Society of Cytopathology’s ASC Bulletin, as well as a reviewer for Diagnostic Cytopathology and CytoJournal.

Assistant Professor The University of Texas Southwestern Medical Center USA

Dr. Kurian’s primary clinical focus is cytopathology with expertise in immediate rapid interpretation and performance of fine needle aspiration, plus general surgical pathology with an interest in thyroid pathology.

Assistant Professor Yale University School of Medicine USA

Breast and Gynecologic pathology; Cytopathology

Guey Chuen Perng, nick name Oscar, earned his Ph.D. from the Department of Microbiology and Immunology at University of California, Davis, and got his postdoc training in Cedars-Sinai Medical Center (CSMC), an affiliated teaching hospital to University of California, Los Angeles. Oscar was an assistant professor at the Department of Ophthalmology at UC Irvine and served as Director of Arbovirology division at AFRIMS, an affiliated research institute to US Military in Bangkok, Thailand. In 2007, Oscar was recruited to the Department of Pathology and Laboratory Medicine as an Associate Professor at Emory University. In 2012, with his outstanding research and insightful knowledge on dengue and global vision on infectious diseases, Oscar was offered to be a faculty at Department of Mcirobiology and Immunology, Medical College, and a faculty at the Center of Infectious Disease and Signaling Research in National Cheng Kung University, Taiwan.

Assistant Professor National Cheng Kung University Taiwan

The research interests are to use up-to-date technology to understand the diseases induced by infectious agents. While thinking about pathogenesis of an infection, we often direct ourselves to immune cells, which perhaps could be critical in understanding of a disease development. But, these cells are originated from hematopoietic organ—bone marrow, of which what role they play in pathogenic cause of a disease remains a mystery. The research focus therefore is to dissect the effects of virus-host interactions on up and down regulation of hematopoietic progenitor cells in bone marrow and innate immune response and/or cytokine productions in pathogen infected subjects, as this could directly affect viral load in the infected organs and therefore is an important factors in the pathogenesis of virus infections.

Assistant Professor Emory University Hospital USA

Renal allograft pathology Pathology Informatics Surgical Pathology

Assistant Professor Emory University USA

Correlating tumor histology with the underlying molecular alterations of a particular tumor and probing the role of tumor stroma in the facilitation/inhibition of tumor growth and metastasis. I am especially interested in the role of the inflammatory stroma in facilitating and promoting phenotypic alterations, such as increased chemotaxis and angioinvasion. Mining the published microarray expression databases in an attempt to identify prognostically useful genetic markers with subsequent confirmation utilizing fresh frozen human tissue and paraffin embedded formalin fixed archived tissues.

Dr. Best is an assistant medical director of the Molecular Genetics Department at ARUP and an assistant professor of clinical pathology at the University of Utah School of Medicine. Dr. Best received his PhD in molecular and cellular pathology at the University of North Carolina School of Medicine and completed a fellowship in clinical molecular genetics at the Vanderbilt University Medical Center in Nashville. He is a member of the American Society for Investigative Pathology, Association for Molecular Pathology, and American Association for the Advancement of Science.

Assistant Professor University of Utah USA

.

Assistant Professor Baylor College of Medicine USA

Dr. Hui specializes in transfusion medicine and coagulation. He covers the blood bank and coagulation services and serves as a consultant for the apheresis service. Dr. Hui’s scope of clinical services is a direct reflection of his research interest in congenital and acquired bleeding disorders especially von Willebrand Diseases and transfusion managements of these patients. He is also actively involved in projects on evidence base transfusion practice and blood management. He is currently participating in several collaborative research projects with investigators from Department of Pediatrics, Department of Hematology and Oncology and Department of Obstetrics and Gynecology.

Dr. Mitul Modi has completed Ph.D and Currently he is working as Visiting Fellow at University Of Texas MD Anderson Cancer Center, USA

Visiting Fellow Department Of Hematopathology University Of Texas MD Anderson Cancer Center USA